Methodology for computational assessment of hemolysis in under‐occlusive roller pumps operated at clinically relevant conditions
Bioengineering & Translational Medicine · 2026-11-10
DOI: 10.1002/btm2.70191 ↗Abstract
Abstract Hemolysis remains a major concern in clinical procedures involving extracorporeal blood circuits, with the blood delivery pump often being its considerable source. This study focuses on roller pumps, which—alongside centrifugal pumps—are the main types used in clinical practice. The objective is to establish a comprehensive methodology for the computational evaluation of hemolysis in under‐occlusive roller pumps, which, compared to fully occlusive operation, have the potential to reduce hemolysis while maintaining sufficient flow performance. The methodology employs transient 2D CFD simulations with a dynamic mesh, while hemolysis is evaluated using a shear‐induced hemolysis model. The governing equations are solved using the transitional low‐ Re SST turbulence model with appropriate prism‐layer refinement at the wall, adhering to values lower than 1, which is essential for accurate hemolysis estimation. In contrast to existing studies, the simulations are complemented by experimental measurements from an in vitro circuit operated under clinically relevant settings, providing realistic boundary conditions and validation support. The core component of the circuit is an in‐house roller pump that enables precise setting and control of the under‐occlusion degree. The proposed methodology enables to estimate and compare hemolysis across five under‐occlusion settings with progressively increasing gap size, each characterized by the corresponding reduction in flow rate. The results indicate that hemolysis levels remain comparable across under‐occlusive settings with flow reductions of up to 37%, with no substantial decrease observed over this range. A more pronounced reduction in hemolysis is observed only at higher degrees of under‐occlusion, corresponding to 50% and 63% flow reductions, which, however, result in clinically unacceptable losses in flow performance. Thus, the simulations suggest that the tightest under‐occlusive setting with 10% flow reduction provides the most favorable balance between hemolysis and flow performance.
EUVIMED